Communicating COVID-19 vaccines: lessons from the dengue vaccine controversy in the Philippines
Abstract
### Summary box
In 2016, the Philippines embarked on an unprecedented mass immunisation campaign against dengue fever, becoming the first Asian nation to authorise the commercial use of Dengvaxia, the dengue vaccine manufactured by the French pharmaceutical Sanofi Pasteur.1 In December 2017, nearly 2 years since the campaign started, Sanofi announced that Dengvaxia may actually cause ‘more severe disease’ in those who have not had previous...
Paper Details
Title
Communicating COVID-19 vaccines: lessons from the dengue vaccine controversy in the Philippines
Published Date
Mar 1, 2021
Journal
Volume
6
Issue
3
Pages
e005422 - e005422
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History